Floatz logo

Busulphan

AIDS-related Primary Effusion Lymphoma

City of Hope Medical CenterPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

19 Active assets in the AIDS-related Primary Effusion Lymphoma cohort.

Asset / SponsorPhaseRating
VINCRISTINE SULFATE
National Cancer Institute (NCI)
Phase 2BBB
Inno-206
National Cancer Institute (NCI)
Phase 2BBB
ETOPOSIDE
National Cancer Institute (NCI)
Phase 2BBB
Cyclophosphamide
National Cancer Institute (NCI)
Phase 2BB
Inno-206
National Cancer Institute (NCI)
Phase 2BB

View all 47 →

Same molecule, other indications

Busulphan is also rated in:

plasma cell myelomaDormant
BBB
Indicative ·
77 / 100
View asset →
myelodysplastic/myeloproliferative neoplasmDormant
BBB
Indicative ·
76 / 100
View asset →
graft versus host diseaseDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →